Related Experiment Video

Updated: May 29, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

New insights in antiplatelet therapy for patients with ischemic stroke

Seemant Chaturvedi1, Pratik Bhattacharya

  • 1Department of Neurology & Stroke Program, Wayne State University, Detroit, MI 48210-2153, USA. schaturv@med.wayne.edu

The Neurologist
|September 2, 2011
PubMed

Insights

Antiplatelet therapy is crucial for acute and long-term stroke and TIA treatment. Aspirin plus dipyridamole is more effective than aspirin alone for secondary stroke prevention with similar bleeding risks.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Antiplatelet therapy is standard for acute and long-term management of noncardioembolic ischemic stroke and transient ischemic attack (TIA).
  • Current antiplatelet agents include aspirin, clopidogrel, and dipyridamole.

Purpose of the Study:

  • To review the safety and efficacy of antiplatelet therapy in ischemic stroke patients.
  • To discuss recent trial data and its impact on treatment guidelines.
  • To explore antiplatelet use in preventing stroke and embolism in atrial fibrillation patients.

Main Methods:

  • Review of clinical trial data on antiplatelet therapies for stroke and TIA.
  • Analysis of comparative efficacy and bleeding risks of different antiplatelet combinations.
  • Discussion of treatment guidelines influenced by trial outcomes.

Main Results:

  • Aspirin combined with dipyridamole demonstrated greater efficacy than aspirin alone for secondary stroke prevention, with comparable bleeding profiles.
  • Aspirin and clopidogrel combination therapy did not show superior efficacy for secondary prevention and was associated with increased bleeding compared to aspirin alone.
  • Dual antiplatelet therapy with aspirin and clopidogrel may offer benefits in acute stroke or for preventing thrombotic events in patients with atrial fibrillation unsuitable for warfarin.

Conclusions:

  • Antiplatelet therapy remains a cornerstone in the acute and long-term management of ischemic stroke and TIA.
  • Further clinical trials are anticipated to refine optimal antiplatelet treatment regimens for various clinical scenarios.
Abstract

More Related Videos

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...